长效合成促肾上腺皮质激素在过敏性哮喘患者和正常受试者中的评估。
Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects.
作者信息
el-Shaboury A H
出版信息
Br Med J. 1968 Sep 14;3(5619):653-5. doi: 10.1136/bmj.3.5619.653.
Abstract
The synthetic polypeptide depot-tetracosactrin (Synacthen-Depot) was given to nine steroid-treated asthmatic patients hypersensitive to animal corticotrophin. Eight had a satisfactory increase in plasma and urinary 17-hydroxycorticosteroids (17-OHCS). The remaining patient had been shown previously to have adrenal suppression. None of the patients developed allergic reactions to depot-tetracosactrin, and seven have been receiving regular injections of the polypeptide twice weekly for the past eight months.In 13 normal subjects intramuscular injections of 1 mg. and 0.5 mg. of depot-tetracosactrin and 40 units of corticotrophin-gel were equally potent in raising the plasma 17-OHCS, but depot-tetracosactrin had a significantly longer action than corticotrophin-gel.
摘要
给9名对动物促肾上腺皮质激素过敏的接受过类固醇治疗的哮喘患者注射了合成多肽长效四促皮质素（长效促皮质素）。其中8名患者血浆和尿中17-羟皮质类固醇（17-OHCS）有令人满意的增加。其余1名患者先前已显示有肾上腺抑制。所有患者均未对长效四促皮质素发生过敏反应，并且在过去8个月中，有7名患者一直每周接受两次该多肽的定期注射。在13名正常受试者中，肌肉注射1毫克和0.5毫克长效四促皮质素以及40单位促皮质素凝胶，在提高血浆17-OHCS方面作用相同，但长效四促皮质素的作用明显比促皮质素凝胶持久。
相似文献
1
Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects.长效合成促肾上腺皮质激素在过敏性哮喘患者和正常受试者中的评估。
Br Med J. 1968 Sep 14;3(5619):653-5. doi: 10.1136/bmj.3.5619.653.
2
Comparison of depot tetracosactrin and corticotrophin gel.长效四促皮质素与促肾上腺皮质激素凝胶的比较
Br Med J. 1969 Dec 20;4(5685):720-3. doi: 10.1136/bmj.4.5685.720.
3
4
Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.信函：1 - 18促肾上腺皮质激素与对长效二十四肽促皮质素的过敏反应
Lancet. 1975 Feb 22;1(7904):456. doi: 10.1016/s0140-6736(75)91528-7.
5
6
Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients.长效合成促肾上腺皮质激素——正常受试者及促肾上腺皮质激素治疗患者的肾上腺反应
Br Med J. 1968 Mar 2;1(5591):557-8. doi: 10.1136/bmj.1.5591.557.
7
[Diagnostic and therapeutic use of synthetic beta 1-24 corticotropin (30'920-BA Synacthen Ciba)].
Vnitr Lek. 1968 Apr;14(4):370-9.
8
[Clinical tests of a new long-acting form of synthetic ACTH: Cortrosyn Depot].
Rev Med Liege. 1969 Nov 1;24(21):762-5.
9
Hyperlipidaemia in asthmatic patients receiving long-term steroid therapy.接受长期类固醇治疗的哮喘患者中的高脂血症。
Br Med J. 1973 Apr 14;2(5858):85-6. doi: 10.1136/bmj.2.5858.85.
10
Prolonged corticotrophic action of a synthetic substituted 1-18 ACTH.一种合成的取代1-18促肾上腺皮质激素的延长促肾上腺皮质作用。
Br Med J. 1971 Sep 25;3(5777):742-3. doi: 10.1136/bmj.3.5777.742.
引用本文的文献
1
Antiasthmatic drugs. II. Therapeutic aspects.抗哮喘药物。II. 治疗方面。
Drugs. 1974;7(5):370-90. doi: 10.2165/00003495-197407050-00006.
2
Effect of prolonged treatment with tetracosactrin on hypothalamo-pituitary-adrenal function in the rat.二十四肽促皮质素长期治疗对大鼠下丘脑-垂体-肾上腺功能的影响。
Br J Pharmacol. 1971 Dec;43(4):804-13. doi: 10.1111/j.1476-5381.1971.tb07216.x.
3
Prolonged corticotrophic action of a synthetic substituted 1-18 ACTH.一种合成的取代1-18促肾上腺皮质激素的延长促肾上腺皮质作用。
Br Med J. 1971 Sep 25;3(5777):742-3. doi: 10.1136/bmj.3.5777.742.
4
Advances in asthma. Treatment.哮喘治疗进展
Br Med J. 1969 Nov 8;4(5679):359-61. doi: 10.1136/bmj.4.5679.359.
5
Synacthen depot used in general practice.长效合成促肾上腺皮质激素在普通医疗中的应用。
Br Med J. 1969 Feb 1;1(5639):316-7. doi: 10.1136/bmj.1.5639.316-c.
6
Antiasthmatic drugs I: pathophysiological and clinical pharmacological aspects.抗哮喘药物I：病理生理学和临床药理学方面
Drugs. 1974;7(5):344-69. doi: 10.2165/00003495-197407050-00005.
7
Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride.类风湿性关节炎患者的钾代谢。长效四氢可的索、螺内酯及口服氯化钾补充剂治疗的效果。
Ann Rheum Dis. 1975 Dec;34(6):506-14. doi: 10.1136/ard.34.6.506.
8
Ultrastructural changes in rat adrenal cortical cells after chronic stimulation with beta 1-24-corticotropin.β1-24促肾上腺皮质激素长期刺激后大鼠肾上腺皮质细胞的超微结构变化
Cell Tissue Res. 1979 Dec;204(2):267-277. doi: 10.1007/BF00234638.
9
Tetracosactrin for the management of asthmatic patients after long-term corticosteroids.二十四肽促皮质素用于长期使用皮质类固醇激素后的哮喘患者管理。
Thorax. 1975 Aug;30(4):426-9. doi: 10.1136/thx.30.4.426.
本文引用的文献
1
EFFECT OF A SYNTHETIC CORTICOTROPHIC POLYPEPTIDE ON ADRENAL FUNCTION IN HYPERSENSITIVE ASTHMATICS.
Lancet. 1965 Feb 6;1(7380):298-301. doi: 10.1016/s0140-6736(65)91030-5.
2
A RAPID TEST OF ADRENOCORTICAL FUNCTION.肾上腺皮质功能的快速检测
Lancet. 1965 Jan 30;1(7379):243-5. doi: 10.1016/s0140-6736(65)91526-6.
3
ADRENOCORTICOTROPIC EFFECTS OF A SYNTHETIC POLYPEPTIDE--BETA 1-24-CORTICOTROPIN--IN MAN.一种合成多肽——β1-24-促肾上腺皮质激素——对人体的促肾上腺皮质作用。
J Clin Endocrinol Metab. 1964 Nov;24:1206-13. doi: 10.1210/jcem-24-11-1206.
4
A SYNTHETIC POLYPEPTIDE (CIBA 30'920-BA) WITH ADRENOCORTICOTROPHIC PROPERTIES.一种具有促肾上腺皮质激素特性的合成多肽（西巴30920-BA）
Med J Aust. 1964 Apr 18;1:590-2.
5
The inhibitory effect of triamcinolone on adrenal function.曲安奈德对肾上腺功能的抑制作用。
J Clin Pathol. 1959 Mar;12(2):140-2. doi: 10.1136/jcp.12.2.140.
6
An improved method for assaying the steroidogenic potency of ACTH.一种用于测定促肾上腺皮质激素（ACTH）类固醇生成能力的改进方法。
Endocrinology. 1955 Nov;57(5):594-8. doi: 10.1210/endo-57-5-594.
7
The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.尿液和血浆中17,21 - 二羟基 - 20 - 酮类固醇的测定
J Biol Chem. 1954 Oct;210(2):923-32.
8
Synacthen Depot--Adrenal response in normal subjects and corticotrophin-treated patients.长效合成促肾上腺皮质激素——正常受试者及促肾上腺皮质激素治疗患者的肾上腺反应
Br Med J. 1968 Mar 2;1(5591):557-8. doi: 10.1136/bmj.1.5591.557.
9
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel.长效二十四肽促皮质素与促皮质素凝胶的促肾上腺皮质作用比较。
Br Med J. 1967 Nov 18;4(5576):391-4. doi: 10.1136/bmj.4.5576.391.
10
Adrenal failure complicating status asthmaticus in steroid-treated patients.肾上腺功能衰竭使接受类固醇治疗的哮喘持续状态患者病情复杂化。
Br Med J. 1966 Dec 17;2(5528):1478-81. doi: 10.1136/bmj.2.5528.1478.
Zotero 插件